Skip to content

Blinding Integrity Assessment Using Rotational Field Transcranial Magnetic Stimualtion (rfTMS) in Healthy Adults

Blinding Integrity Assessment Using Rotational Field Transcranial Magnetic Stimulation (rfTMS) Delivered Through a Multi-Channel Deep Coil Stimulation System in Healthy Adults

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07706790
Enrollment
60
Registered
2026-07-16
Start date
2025-09-09
Completion date
2026-07-05
Last updated
2026-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Keywords

Noninvasive Brain Stimulation, Transcranial Magnetic Stimulation (TMS), Rotational Field TMS (rfTMS), Deep Coil TMS (dTMS), Multi-Channel, Sham-Blinding, Masking Method, Ramp-Up/Down, Healthy

Brief summary

This study evaluates the effectiveness of an improved blinding method using rotational field transcranial magnetic stimulation (rfTMS) delivered through a multi-channel deep coil system (Brainsway, Jerusalem, Israel). Healthy volunteers receive a single session of either Active or Sham stimulation over the medial prefrontal cortex. The study assesses whether the Sham condition sufficiently masks the sensory characteristics of Active stimulation. Findings will support the optimization of blinding procedures for future deep TMS (dTMS) trials.

Detailed description

Effective Sham blinding is essential for the validity of deep TMS (dTMS) clinical trials. Existing Sham methods often fail to adequately mimic the sensory experience of Active stimulation, allowing participants to infer their treatment allocation. This prospective, randomized, double-blind study examines blinding integrity using rotational field transcranial magnetic stimulation (rfTMS) implemented on a multi-channel deep coil system (Brainsway, Jerusalem, Israel). Participants receive either Active stimulation or a Sham condition matched for coil placement, auditory and tactile experience but without inducing field in the brain. Results will inform the design of future dTMS studies.

Interventions

DEVICESham rfTMS

Participants receive a single session of Sham rfTMS matched for coil placement, auditory and tactile output but without inducing field in the brain. Stimulation parameters are identical as in Active rfTMS.

DEVICEActive rfTMS

Participants receive a single session of 10 HZ high-frequence Active rfTMS delivered via a multi-channel with deep coil system over the medial prefrontal cortex. Stimulation lasts \~20 minutes and consists of 100 trains, 3 seconds each, separated by 9-seconds inter-train intervals (3000 pulses in total), delivered at 90% of individual foot motor cortex resting motor threshold.

Sponsors

Soroka University Medical Center
Lead SponsorOTHER
Ben-Gurion University of the Negev
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults aged 18-65 * Hebrew or English speakers * No neurological, psychiatric, or developmental disorders * No contraindications for TMS * Able to provide informed consent

Exclusion criteria

* History of seizure * Metal implants in the head or neck * Pacemakers or implanted stimulators * Pregnancy * Current psychoactive medication affecting seizure threshold * Any contraindication listed in standard TMS safety guidelines

Design outcomes

Primary

MeasureTime frameDescription
Blinding response distributionImmediately post-sessionDistribution of participant responses on a five-scale blinding questionnaire indicating perceived stimulation type (Active vs Sham), reported as the proportion of participants selecting each response category.

Countries

Israel

Contacts

STUDY_DIRECTORAlona Ron Levy, PhD Candidate in Neuroscience

Ben-Gurion University of the Negev

PRINCIPAL_INVESTIGATORIuly Treger, MD, Professor

Soroka University Medical Center

STUDY_CHAIRAbraham Zangen, Professor

Ben-Gurion University of the Negev

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 17, 2026